| Literature DB >> 35720851 |
Qi Gao1,2,3, Yongzhi Feng1,2, Yunlong Yang1,3, Yizhuo Luo1,4, Ting Gong1,4, Heng Wang1,2,3, Lang Gong1,2,3, Guihong Zhang1,2,3, Zezhong Zheng1,2,3.
Abstract
Since the first outbreak of ASFV genotype II in China in 2018, ASF has posed a significant threat to the swine industry. After the emergence of genotype I in China in 2020, the epidemic prevention and control have become more difficult. No effective commercial vaccine is currently available, and the disease is difficult to eradicate; therefore, the identification of the ASFV genotype is critical to establish biosafety control measures. In this study, a dual real-time PCR detection method based on B646L and E183L genes was developed to distinguish between ASFV genotypes I and II by specifically amplifying the genotype I E183L gene. The method is strongly specific, detects B646L and E183L genes simultaneously, and does not cross-react with PEDV, PCV, PRRSV, PRV, and CSFV. The double real-time PCR detection of ASFV genotypes I and II showed a B646L amplification curve, and only genotype I showed an E183L amplification curve, consistent with our expectations. The method has high sensitivity and the lowest copy numbers detected for recombinant plasmids B646L and E183L were 1.07 × 102 and 3.13 × 104 copies/μL, respectively. The method is reproducible, and the coefficient of variation for detecting the coefficient of variation (CV) values of the two recombinant plasmids was <2%. Seven samples were positive and 277 were negative, and the results of the two methods were consistent. The dual real-time PCR presented in this study provides a rapid detection method for the identification of ASFV genotypes I and II, which may lead to improving efficient prevention and control measures for ASF in China.Entities:
Keywords: ASFV; B646L gene; E183L gene; dual real-time PCR; genotypes I and II
Year: 2022 PMID: 35720851 PMCID: PMC9198542 DOI: 10.3389/fvets.2022.882824
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Primers and probes.
|
|
|
|
|---|---|---|
| B646L-F | ATAGAGATACAGCTCTTCCAG | 159 |
| B646L-R | GTATGTAAGAGCTGCAGAAC | |
| B646L-Probe | TATCGATAAGATTGAT | |
| E183L-F | CGCGAGTGCTCATCCGACT | 73 |
| E183L-R | GCTTCACAAACAATGTCGGCT | |
| E183L-Probe | CATCCGACTGAGCCTTACACGACAGTCACT |
The amplification reaction conditions.
|
|
|
|---|---|
| 2 × AceQ Universal U + Probe Master Mix V2 | 10.0 |
| B646L-F | 0.4 |
| B646L-R | 0.4 |
| B646L-Probe | 0.2 |
| E183L-F | 0.4 |
| E183L-R | 0.4 |
| E183L-Probe | 0.2 |
| Template DNA | 2 |
| DEPC H2O | up to 20 |
PCR program, 37 °C for 2 min; 95 °C for 5 min; 95 °C for 5 min; 95 °C for 10 s, 60 °C for 30 s, 40 cycles.
Figure 1Amplification curve for the FAM channel determined through nucleic acid double fluorescence quantitative PCR of ASFV genotypes I and II, ASFV genotypes I and II mixed samples, and negative pig samples.
Figure 2Amplification curve for the HEX channel determined through nucleic acid double fluorescence quantitative PCR of ASFV genotypes I and II, ASFV genotypes I and II mixed samples, and negative pig samples.
Figure 3Amplification curve for the FAM channel of ASFV genotypes I and II, PEDV, PRRSV, PRV, PCV-2, CSFV, and negative nucleic acid pig samples determined through dual real-time PCR.
Figure 4Amplification curve for the HEX channel of ASFV genotypes I and II, PEDV, PRRSV, PRV, PCV-2, CSFV, and negative nucleic acid pig samples determined through dual real-time PCR.
Figure 5Determination of the dual real-time PCR sensitivity. (A) B646L gene sensitivity test. (B) E183L gene sensitivity test.
Figure 6Establishment of a dual real-time PCR standard curve. (A) Standard curve for plasmid pUC57-B646L, y = −3.258x + 41.69, R2 = 0.994. (B) Standard curve for plasmid pCAGGS-E183L, y = −3.639x + 48.47, R2 = 0.997.
Intra-reproducibility and intra-repeatability of B646L gene by dual real-time PCR.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| 11.44 | 11.26 | |||||||
| 10−2 | 11.82 | 11.69 | 0.18 | 1.57 | 11.54 | 11.49 | 0.21 | 1.86 |
| 11.56 | 11.68 | |||||||
| 15.47 | 15.74 | |||||||
| 10−3 | 15.72 | 15.53 | 0.27 | 1.73 | 15.53 | 15.56 | 0.17 | 1.07 |
| 15.34 | 15.41 | |||||||
| 19.15 | 19.26 | |||||||
| 10−4 | 19.29 | 19.47 | 0.25 | 1.27 | 19.65 | 19.37 | 0.25 | 1.28 |
| 19.64 | 19.19 | |||||||
| 22.56 | 22.67 | |||||||
| 10−5 | 22.89 | 22.59 | 0.42 | 1.88 | 22.91 | 22.72 | 0.17 | 0.73 |
| 22.29 | 22.59 | |||||||
| 25.53 | 25.34 | |||||||
| 10−6 | 25.23 | 25.5 | 0.39 | 1.52 | 25.72 | 25.54 | 0.19 | 0.75 |
| 25.78 | 25.56 | |||||||
| 28.69 | 28.43 | |||||||
| 10−7 | 28.29 | 28.43 | 0.20 | 0.70 | 28.65 | 28.46 | 0.18 | 0.64 |
| 28.57 | 28.29 | |||||||
| 32.15 | 32.67 | |||||||
| 10−8 | 32.06 | 32.15 | 0.13 | 0.40 | 32.25 | 32.40 | 0.23 | 0.72 |
| 32.24 | 32.29 | |||||||
| 34.57 | 34.99 | |||||||
| 10−9 | 34.98 | 34.87 | 0.16 | 0.45 | 35.08 | 34.95 | 0.15 | 0.44 |
| 34.76 | 34.78 |
Intra-reproducibility and intra-repeatability of E183L gene by dual real-time PCR/.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| 13.75 | 13.69 | |||||||
| 10−1 | 13.68 | 13.57 | 0.16 | 1.14 | 13.42 | 13.61 | 0.16 | 1.19 |
| 13.46 | 13.71 | |||||||
| 17.29 | 17.52 | |||||||
| 10−2 | 17.58 | 17.68 | 0.14 | 0.80 | 17.38 | 17.54 | 0.18 | 1.00 |
| 17.78 | 17.73 | |||||||
| 21.01 | 21.11 | |||||||
| 10−3 | 21.54 | 21.43 | 0.16 | 0.73 | 21.45 | 21.39 | 0.26 | 1.19 |
| 21.32 | 21.61 | |||||||
| 25.04 | 25.28 | |||||||
| 10−4 | 25.56 | 25.70 | 0.19 | 0.74 | 25.49 | 25.50 | 0.22 | 0.86 |
| 25.83 | 25.72 | |||||||
| 28.53 | 28.41 | |||||||
| 10−5 | 28.03 | 28.25 | 0.33 | 1.08 | 28.32 | 28.28 | 0.16 | 0.56 |
| 28.46 | 28.10 | |||||||
| 31.92 | 32.01 | |||||||
| 10−6 | 32.45 | 32.36 | 0.13 | 0.42 | 32.54 | 32.28 | 0.27 | 0.82 |
| 32.26 | 32.29 |
Figure 7Analysis of clinical samples. (A) Amplification curve for the FAM channel determined through nucleic acid dual fluorescence quantitative PCR of pig clinical samples (284). Pig clinical samples (284) were analyzed using dual real-time PCR; seven samples were ASFV-positive. (B) Amplification curve for the HEX channel determined through nucleic acid dual fluorescence quantitative PCR of pig clinical samples (284) and the remaining 277 samples were negative.